Essential role of IL-10/STAT3 in chronic stress-induced immune suppression

Brain, Behavior, and Immunity

Volumn 36, Issue , 2014, Pages 118-127

  Hu, Dan ^a,b   Wan, Lei ^c   Chen, Michael ^a   Caudle, Yi ^a   LeSage, Gene ^a   Li, Qinchuan ^d   Yin, Deling ^a  

^a East Tennessee State University   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c INSTITUTE OF FORENSIC SCIENCE   (China)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Chronic stress; Immune suppression; P38; STAT3; TLR4

Indexed keywords

4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHRONIC STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMOBILIZATION STRESS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; WESTERN BLOTTING;

ANIMALS; INTERLEUKIN-10; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; RESTRAINT, PHYSICAL; SPLEEN; STAT3 TRANSCRIPTION FACTOR; STRESS, PSYCHOLOGICAL; TOLL-LIKE RECEPTOR 4;

EID: 84891826010     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.10.016     Document Type: Article

References (62)

1. Ahmed S.T., Ivashkiv L.B. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J. Immunol. 2000, 165:5227-5237.
2. Bode J.G., Ehlting C., Haussinger D. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell. Signal. 2012, 24:1185-1194.
3. Braun D.A., Fribourg M., Sealfon S.C. Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation. J. Biol. Chem. 2013, 288:2986-2993.
4. Cesta M.F. Normal structure, function, and histology of the spleen. Toxicol. Pathol. 2006, 34:455-465.
5. Chan L.L., Cheung B.K., Li J.C., Lau A.S. A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-gamma-induced MHC class II molecule on primary human blood macrophages. J. Leukoc. Biol. 2010, 88:303-311.
6. Cheng F., Wang H.W., Cuenca A., Huang M., Ghansah T., Brayer J., Kerr W.G., Takeda K., Akira S., Schoenberger S.P., Yu H., Jove R., Sotomayor E.M. A critical role for Stat3 signaling in immune tolerance. Immunity 2003, 19:425-436.
7. Clougherty J.E., Rossi C.A., Lawrence J., Long M.S., Diaz E.A., Lim R.H., McEwen B., Koutrakis P., Godleski J.J. Chronic social stress and susceptibility to concentrated ambient fine particles in rats. Environ. Health Perspect. 2010, 118:769-775.
8. Cohen S., Janicki-Deverts D., Miller G.E. Psychological stress and disease. JAMA 2007, 298:1685-1687.
9. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 2001, 166:4312-4318.
10. Cui W., Liu Y., Weinstein J.S., Craft J., Kaech S.M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011, 35:792-805.
11. Dragos D., Tanasescu M.D. The effect of stress on the defense systems. J. Med. Life 2010, 3:10-18.
12. El Kasmi K.C., Holst J., Coffre M., Mielke L., de Pauw A., Lhocine N., Smith A.M., Rutschman R., Kaushal D., Shen Y., Suda T., Donnelly R.P., Myers M.G., Alexander W., Vignali D.A., Watowich S.S., Ernst M., Hilton D.J., Murray P.J. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 2006, 177:7880-7888.
13. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N. Y. Acad. Sci. 2002, 966:290-303.
14. Gu H.F., Tang C.K., Yang Y.Z. Psychological stress, immune response, and atherosclerosis. Atherosclerosis 2012, 223:69-77.
15. Hamidullah, Changkija B., Konwar R. Role of interleukin-10 in breast cancer. Breast Cancer Res. Treat. 2012, 133:11-21.
16. Hernandez J., Carrasco J., Belloso E., Giralt M., Bluethmann H., Kee Lee D., Andrews G.K., Hidalgo J. Metallothionein induction by restraint stress: role of glucocorticoids and IL-6. Cytokine 2000, 12:791-796.
17. Hua F., Ha T., Ma J., Li Y., Kelley J., Gao X., Browder I.W., Kao R.L., Williams D.L., Li C. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol. 2007, 178:7317-7324.
18. Iwata-Kajihara T., Sumimoto H., Kawamura N., Ueda R., Takahashi T., Mizuguchi H., Miyagishi M., Takeda K., Kawakami Y. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors. J. Immunol. 2011, 187:27-36.
19. Kang B.Y., Kim E., Kim T.S. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell. Signal. 2005, 17:665-673.
20. Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu. Rev. Psychol. 2002, 53:83-107.
21. Kim C., Sano Y., Todorova K., Carlson B.A., Arpa L., Celada A., Lawrence T., Otsu K., Brissette J.L., Arthur J.S., Park J.M. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 2008, 9:1019-1027.
22. Kim H.R., Moon S., Lee H.K., Kang J.L., Oh S., Seoh J.Y. Immune dysregulation in chronic stress: a quantitative and functional assessment of regulatory T cells. Neuroimmunomodulation 2012, 19:187-194.
23. Korhonen R., Huotari N., Hommo T., Leppanen T., Moilanen E. The expression of interleukin-12 is increased by MAP kinase phosphatase-1 through a mechanism related to interferon regulatory factor 1. Mol. Immunol. 2012, 51:219-226.
24. Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mule J., Kerr W.G., Jove R., Pardoll D., Yu H. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 2005, 11:1314-1321.
25. Lamkin D.M., Sloan E.K., Patel A.J., Chiang B.S., Pimentel M.A., Ma J.C., Arevalo J.M., Morizono K., Cole S.W. Chronic stress enhances progression of acute lymphoblastic leukemia via beta-adrenergic signaling. Brain Behav. Immun. 2012, 26:635-641.
26. Lang R., Patel D., Morris J.J., Rutschman R.L., Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 2002, 169:2253-2263.
27. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 2004, 202:96-105.
28. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 2002, 3:651-662.
29. Li H., Chen L., Zhang Y., Lesage G., Zhang Y., Wu Y., Hanley G., Sun S., Yin D. Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a beta-arrestin 2 dependent manner. J. Neuroimmunol. 2011, 233:73-79.
30. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458.
31. Liu N., Liu J.T., Ji Y.Y., Lu P.P. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells. Life Sci. 2010, 87:367-374.
32. Lu X.T., Liu Y.F., Zhao L., Li W.J., Yang R.X., Yan F.F., Zhao Y.X., Jiang F. Chronic psychological stress induces vascular inflammation in rabbits. Stress 2013, 16:87-98.
33. Lucini D., Pagani M. From stress to functional syndromes: an internist's point of view. Eur. J. Intern. Med. 2011, 23:295-301.
34. Mankan A.K., Greten F.R. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors. Expert Opin. Investig. Drugs 2011, 20:1263-1275.
35. Melillo J.A., Song L., Bhagat G., Blazquez A.B., Plumlee C.R., Lee C., Berin C., Reizis B., Schindler C. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J. Immunol. 2010, 184:2638-2645.
36. Murray P.J. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 2006, 6:379-386.
37. Murray P.J., Smale S.T. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 2012, 13:916-924.
38. Park J.M., Greten F.R., Wong A., Westrick R.J., Arthur J.S., Otsu K., Hoffmann A., Montminy M., Karin M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity 2005, 23:319-329.
39. Pattison M.J., Mackenzie K.F., Arthur J.S. Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback. J. Immunol. 2012, 189:2784-2792.
40. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929-979.
41. Redford P.S., Murray P.J., O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal. Immunol. 2011, 4:261-270.
42. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004, 5:617-625.
43. Riebe C., Pries R., Schroeder K.N., Wollenberg B. Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway. Anticancer Res. 2011, 31:3819-3825.
44. Rincon M., Davis R.J. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 2009, 228:212-224.
45. Roers A., Siewe L., Strittmatter E., Deckert M., Schlüter D., Stenzel W., Gruber A.D., Krieg T., Rajewsky K., Müller W. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 2004, 200:1289-1297.
46. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
47. Sato T., Terai M., Tamura Y., Alexeev V., Mastrangelo M.J., Selvan S.R. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol. Res. 2011, 51:170-182.
48. Sesti-Costa R., Ignacchiti M.D., Chedraoui-Silva S., Marchi L.F., Mantovani B. Chronic cold stress in mice induces a regulatory phenotype in macrophages: correlation with increased 11beta-hydroxysteroid dehydrogenase expression. Brain Behav. Immun. 2012, 26:50-60.
49. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
50. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
51. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
52. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
53. Williams L., Bradley L., Smith A., Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 2004, 172:567-576.
54. Wills-Karp M. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 2001, 107:9-18.
55. Wilson E.B., Brooks D.G. The role of IL-10 in regulating immunity to persistent viral infections. Curr. Top. Microbiol. Immunol. 2011, 350:39-65.
56. Wolfle S.J., Strebovsky J., Bartz H., Sahr A., Arnold C., Kaiser C., Dalpke A.H., Heeg K. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J. Immunol. 2011, 41:413-424.
57. Yamawaki Y., Kimura H., Hosoi T., Ozawa K. MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 298:R403-410.
58. Yin D., Tuthill D., Mufson R.A., Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 2000, 191:1423-1428.
59. Yin D., Zhang Y., Stuart C., Miao J., Zhang Y., Li C., Zeng X., Hanley G., Moorman J., Yao Z., Woodruff M. Chronic restraint stress modulates expression of genes in murine spleen. J. Neuroimmunol. 2006, 177:11-17.
60. Zhang Y., Woodruff M., Zhang Y., Miao J., Hanley G., Stuart C., Zeng X., Prabhakar S., Moorman J., Zhao B., Yin D. Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression. J. Neuroimmunol. 2008, 194:115-122.
61. Zheng Y., Guo Z., He W., Yang Y., Li Y., Zheng A., Li P., Zhang Y., Ma J., Wen M., Yang M., An H., Ji G., Yu Y. Ephedrine hydrochloride protects mice from LPS challenge by promoting IL-10 secretion and inhibiting proinflammatory cytokines. Int. Immunopharmacol. 2012, 13:46-53.
62. Zhu J., Mohan C. Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm. 2010, 2010:781235.